The role of liver transaminase levels in methotrexate intolerance in juvenile idiopathic arthritis-a cross-sectional study

Rheumatol Int. 2023 May;43(5):875-880. doi: 10.1007/s00296-023-05297-3. Epub 2023 Mar 15.

Abstract

Methotrexate (MTX) plays a key role when treating juvenile idiopathic arthritis (JIA), but MTX-intolerance is challenging. MTX-treatment might affect the liver, causing elevated levels of alanine aminotransferase (ALT), yet the role of ALT-levels in MTX-intolerance in JIA remains unclear. Our study aimed to investigate the association between ALT-levels during MTX-treatment and MTX-intolerance in JIA. Children (> 9 years old) diagnosed with JIA and treated with MTX (> 6 weeks) were eligible for enrollment. MTX-intolerance was assessed using the Methotrexate Intolerance Severity Score (MISS), completed by the parents, and defined as MISS ≥ 6 with at least 1 point for a behavioral/anticipatory/associative symptom. ALT-levels were determined at enrollment. A total of 118 children were enrolled (80 girls; 38 boys). MTX-intolerance was registered in 61%. ALT-levels did not differ between the MTX-intolerant group (median = 17.0 U/L [IQR: 14.0-26.0]) and the MTX-tolerant group (median = 20.5 U/L [IQR: 16.0-27.5]; p = 0.17). MTX-intolerance was prevalent in around 60% of both boys and girls. Nine out of 50 MTX-intolerant girls had elevated ALT-levels compared to 0/22 MTX-intolerant boys, however, there was no difference in median ALT levels between the two groups. Furthermore, the MTX-intolerant girls had a higher MISS (median = 14.0 [IQR: 9.3-17]) than the MTX-intolerant boys (median = 10.0 [IQR: 7.3-12]; p = 0.009). Our study did not find a difference in ALT-levels between MTX-intolerant and MTX-tolerant children. However, only MTX-intolerant girls and no MTX-intolerant boys showed elevated ALT-levels.

Keywords: Juvenile idiopathic arthritis; Liver transaminases; Methotrexate; Methotrexate intolerance; Methotrexate intolerance severity score.

MeSH terms

  • Alanine Transaminase
  • Antirheumatic Agents* / adverse effects
  • Arthritis, Juvenile* / drug therapy
  • Child
  • Cross-Sectional Studies
  • Female
  • Humans
  • Liver
  • Male
  • Methotrexate / adverse effects
  • Treatment Outcome

Substances

  • Methotrexate
  • Antirheumatic Agents
  • Alanine Transaminase